Memantine for comorbid obsessive-compulsive disorder and asperger disorder suggests a link in glutamatergic dysregulation

Journal of Clinical Psychopharmacology

Volumn 31, Issue 5, 2011, Pages 673-675

  Bernhardt, Erica B ^a   Walsh, Kelda H ^a   Posey, David J ^a   McDougle, Christopher J ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; ATOMOXETINE; DEXMETHYLPHENIDATE; FLUOXETINE; FLUVOXAMINE; GLUTAMIC ACID; LISDEXAMFETAMINE; MEMANTINE; MIRTAZAPINE; PAROXETINE; RISPERIDONE; SERTRALINE; VENLAFAXINE;

ADOLESCENT; ANXIETY DISORDER; ASPERGER SYNDROME; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL GLOBAL IMPRESSION SCALE; COGNITIVE THERAPY; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DOSE INCREASE; GILLES DE LA TOURETTE SYNDROME; HUMAN; INCREASED APPETITE; INTELLIGENCE QUOTIENT; LETTER; MALE; MOTOR DYSFUNCTION; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; SIDE EFFECT; SOCIAL BEHAVIOR; TREATMENT OUTCOME; TREATMENT RESPONSE; WEIGHT GAIN;

ADOLESCENT; ASPERGER SYNDROME; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; MALE; MEMANTINE; OBSESSIVE-COMPULSIVE DISORDER; TREATMENT OUTCOME;

EID: 80052467721     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31822c92d4     Document Type: Letter

References (15)

1. Koran LM, Hanna GL, Hollander E, et al. Practice guidelines for the treatment of patients with obsessive-compulsive disorder. Am J Psychiatry. 2007; 164(suppl 7):5-53.
2. McDougle CJ, Goodman WK, Leckman JF, et al. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. Arch Gen Psychiatry. 1994;51(4):302-308. (Pubitemid 24127303)
3. McDougle CJ, Epperson CN, Pelton GH, et al. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Arch Gen Psychiatry. 2000;57(8):794-801. (Pubitemid 30650116)
4. Connor KM, Payne VM, Gadde KM, et al. The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients. J Clin Psychiatry. 2005;66: 49-51.
5. Aboujaoude E, Barry JJ, Gamel N. Memantine augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial. J Clin Psychopharmacol. 2009;29(1):51-55.
6. Stewart SE, Jenike EA, Hezel DM, et al. A single-blinded case-control study of memantine in severe obsessive-compulsive disorder. J Clin Psychopharmacol. 2010;30(1):34-39.
7. Wink LK, Plawecki MH, Erickson CA, et al. Emerging drugs for the treatment of symptoms associated with autism spectrum disorders. Expert Opin Emerg Drugs. 2010;15(3):481-494.
8. Erickson CA, Posey DJ, Stigler KA, et al. A retrospective study of memantine in children and adolescents with pervasive developmental disorders. Psychopharmacology. 2007;191(1):141-147. (Pubitemid 46294942)
9. Owley T, Salt J, Guter S, et al. A prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2006;16(5): 517-524. (Pubitemid 44737207)
10. Rosenberg DR, MacMaster FP, Keshavan MS, et al. Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatry. 2000;39(9): 1096-1103.
11. Coric V, Taskiran S, Pittenger C, et al. Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial. Biol Psychiatry. 2005;58:424-428. (Pubitemid 41219711)
12. Kushner MG, Kim SW, Donahue C, et al. D-Cycloserine augmented exposure therapy for obsessive-compulsive disorder. Biol Psychiatry. 2007;62(8):835-838. (Pubitemid 47488217)
13. Wald R, Dodman N, Shuster L. The combined effects of memantine and fluoxetine on an animal model of obsessive compulsive disorder. Exp Clin Psychopharmacol. 2009;17(3):191-197.
14. Wachtel L. Riluzole for affective and behavioral disturbance in autism. Eur Psychiatry. 2009;24(1):512.
15. Posey DJ, Kem DL, Swiezy NB, et al. A pilot study of D-cycloserine in autistic disorder. Am J Psychiatry. 2004;161:2115-2117. (Pubitemid 39441414)